Search

Displaying results 7071 - 7080 of 10000 in total
  1. Drug

    Pemlimogene merolisbac

    go.drugbank.com/drugs/DB16286
    Investigational

    Pemlimogene merolisbac is under investigation in clinical trial NCT03371381 (An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab … Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung).

    Synonyms: Recombinant live-attenuated double-deleted (ladd) strain of listeria monocytogenes (lm .delta.acta/.delta.inlb) expressing a fusion protein comprising the n-terminal 100 amino acids of the lm acta protein
  2. Indication

    Basal Cell Carcinoma (BCC)

    go.drugbank.com/conditions/DBCOND0040396
    Drugs: Aminolevulinic acid
    Synonyms: (Basal cell carcinoma) or (Bowen's disease) or (rodent ulcer) or (skin Ca - excluding melanoma) or (Ca skin - other)
  3. Drug

    Acecainide

    go.drugbank.com/drugs/DB17602
    Experimental

    Acecainide is an investigational anti-arrhythmia drug.

    Synonyms: Acetylprocainamide, n-, N-acetylprocainamideCategories: Benzamides and benzamide derivatives
  4. Drug

    Patupilone

    go.drugbank.com/drugs/DB03010
    Investigational

    Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol.

  5. Drug

    Eldelumab

    go.drugbank.com/drugs/DB06116
    Investigational

    bowel disease and multiple sclerosis. … MDX-1100, a fully human antibody that targets IP10 (also known as CXCL10), a chemokine expressed in association with multiple inflammatory disease indications, such as rheumatoid arthritis, inflammatory

    Categories: Amino Acids, Peptides, and Proteins
  6. Drug

    Pracinostat

    go.drugbank.com/drugs/DB05223
    Investigational

    Data demonstrate that Pracinostat is a potent and effective anti-tumor drug with potential as an oral therapy for a variety of human hematological and solid tumors. … Pracinostat is a novel HDAC inhibitor with improved in vivo properties compared to other HDAC inhibitors currently in clinical trials, allowing oral dosing.

  7. Drug

    Zuretinol acetate

    go.drugbank.com/drugs/DB12112
    Investigational

    Zuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis).

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Vibrio cholerae Inaba 48 classical biotype, heat inactivated

    go.drugbank.com/drugs/DB15485
    ApprovedInvestigational

    Mixtures: DUKORAL VACCINE AGAINST CHOLERA AND ETEC-DIARRHOEA
  9. Drug

    Vibrio cholerae Ogawa 50 classical biotype, heat inactivated

    go.drugbank.com/drugs/DB15486
    ApprovedInvestigational

    Mixtures: DUKORAL VACCINE AGAINST CHOLERA AND ETEC-DIARRHOEA
  10. Drug

    TTAX01

    go.drugbank.com/drugs/DB17928
    Investigational

    TTAX01 is a cryopreserved human umbilical cord product being developed by TissueTech.[L47246]